Diseases which cause generalized peripheral neuropathy: a systematic review

References

• Spencer NJ, Hu H. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat Rev Gastroenterol Hepatol. 2020;17(6):338–351.
   PubMed Web of Science ®Google Scholar
• Maxwell PJ, Montgomery SC, Cavallazzi R, et al. What micronutrient deficiencies should be considered in distinct neurological disorders? Curr Gastroenterol Rep. 2013;15(7):331.
   PubMedGoogle Scholar
• Coon EA, Cutsforth-Gregory JK, Benarroch EE. Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord. 2018;33(3):349–358.
   PubMed Web of Science ®Google Scholar
• Schofield JR. Autonomic neuropathy—in its many guises—as the initial manifestation of the antiphospholipid syndrome. Immunol Res. 2017;65(2):532–542.
   PubMed Web of Science ®Google Scholar
• Oaklander AL. Immunotherapy prospects for painful small-fiber sensory neuropathies and ganglionopathies. Neurotherapeutics. 2016;13(1):108–117.
   PubMed Web of Science ®Google Scholar
• Novak P. Autonomic disorders. Am J Med. 2019;132(4):420–436.
   PubMed Web of Science ®Google Scholar
• Hanewinckel R, Drenthen J, van Oijen M, et al. Prevalence of polyneuropathy in the middle-aged and elder population. Neurology. 2016;87(18):1892–1898.
   PubMed Web of Science ®Google Scholar
• Ohlsson B, Dahlin LB, Englund E, et al. Autonomic and peripheral neuropathy with reduced intraepidermal nerve fiber density can be observed in patients with gastrointestinal dysmotility. Clin Case Rep. 2020;8(1):142–148.
   PubMed Web of Science ®Google Scholar
• Peruzzi N, Veress B, Dahlin L, et al. 3D analysis of the myenteric plexus of the human bowel by x-ray phase-contrast tomography – a future method? Scand J Gastroenterol. 2020;55(10):1261–1267.
   PubMed Web of Science ®Google Scholar
• Eckermann M, Peruzzi N, Frohn J, et al. 3D nanotomography of unstained human skin biopsies may differentiate morphological structures in the dermis and epidermis between subjects. Skin Res Tech. 2020.
   Google Scholar
• Gebremedhn EG, Shortland PJ, Mahns DA. The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review. BMC Cancer. 2018;18(1):410.
   PubMedGoogle Scholar
• Eltobgy M, Oweira H, Petrausch U, et al. Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review. Expert Rev Neurother. 2017;17(7):725–736.
   PubMed Web of Science ®Google Scholar
• Briani C, Dalla Torre C, Citton V, et al. Cobalamin deficiency: clinical picture and radiological findings. Nutrients. 2013;5(11):4521–4539.
   PubMed Web of Science ®Google Scholar
• Frantz DJ. Neurologic complications of bariatric surgery: involvement of central, peripheral, and enteric nervous systems. Curr Gastroenterol Rep. 2012;14(4):367–372.
   PubMedGoogle Scholar
• Moris G. Inflammatory bowel disease: an increased risk factor for neurological complications. World J Gastroenterol. 2014;20:1228–1237.
   PubMed Web of Science ®Google Scholar
• Jericho H, Guandalini S. Extra-intestinal manifestation of celiac disease in children. Nutrients. 2018;10:755.
   Web of Science ®Google Scholar
• Bengtsson M, Hammar O, Mandl T, et al. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011;11(1):122.
   PubMedGoogle Scholar
• Freeman R. Autonomic peripheral neuropathy. Neurol Clin. 2007;25(1):277–301.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Wingate D, Hongo M, Kellow J, et al. Disorders of gastrointestinal motility: towards a new classification. J Gastroenterol Hepatol. 2002;17:S1–S14.
   PubMed Web of Science ®Google Scholar
• Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol. 2008;103(3):776–787.
   PubMed Web of Science ®Google Scholar
• Amaral TN, Peres FA, Lapa AT, et al. Neurologic involvement in scleroderma: a systematic review. Semin Arthritis Rheum. 2013;43(3):335–347.
   PubMed Web of Science ®Google Scholar
• Esposito S, Longo MR. Guillain-Barré syndrome. Autoimmun Rev. 2017;16(1):96–101.
   PubMed Web of Science ®Google Scholar
• Carod-Artal FJ. Infectious diseases causing autonomic dysfunction. Clin Auton Res. 2018;28(1):67–81.
   PubMed Web of Science ®Google Scholar
• Higashimoto T, Baldwin EE, Gold JI, et al. Reflex sympathetic dystrophy: complex regional pain syndrome type I in children with mitochondrial disease and maternal inheritance. Arch Dis Child. 2008;93(5):390–397.
   PubMed Web of Science ®Google Scholar
• Benarroch EE. The clinical approach to autonomic failure in neurological disorders. Nat Rev Neurol. 2014;10(7):396–407.
   PubMed Web of Science ®Google Scholar
• Sasaki H, Kawamura N, Dyck PJ, et al. Spectrum of diabetic neuropathies. Diabetol Int. 2020;11(2):87–96.
   PubMed Web of Science ®Google Scholar
• Vinik AI, Maser RE, Mitchell BD, et al. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553–1579.
   PubMed Web of Science ®Google Scholar
• Sharma JK, Rohatgi A, Sharma D. Diabetic autonomic neuropathy: a clinical update. J R Coll Physicians Edinb. 2020;50(3):269–273.
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–2293.
   PubMed Web of Science ®Google Scholar
• Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154.
   PubMed Web of Science ®Google Scholar
• Sharma V, Verma P, Guleria R, et al. Diabetic pandemonium. Int J Pharm Sci Rev Res. 2012;17:65–72.
   Google Scholar
• Hund E, Linke RP, Willig F, et al. Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment. Neurology. 2001;56(4):431–435.
   PubMed Web of Science ®Google Scholar
• Kelly JJ Jr., Kyle RA, O'Brien PC, et al. The natural history of peripheral neuropathy in primary systemic amyloidosis. Ann Neurol. 1979;6(1):1–7.
   PubMed Web of Science ®Google Scholar
• Lim AY, Lee JH, Jung KS, et al. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience. Korean J Intern Med. 2015;30(4):496–505.
   PubMed Web of Science ®Google Scholar
• Suhr OB, Svendsen IH, Andersson R, et al. Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med. 2003;254(3):225–235.
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Ueda M, Koike H, et al. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet J Rare Dis. 2018;13(1):6.
   PubMed Web of Science ®Google Scholar
• Nozaki K, Judson MA. Neurosarcoidosis. Curr Treat Options Neurol. 2013;15(4):492–504.
   PubMed Web of Science ®Google Scholar
• Wakabayashi K, Mori F, Tanji K, et al. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol. 2010;120(1):1–12.
   PubMed Web of Science ®Google Scholar
• Gelpi E, Navarro-Otano J, Tolosa E, et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord. 2014;29(8):1010–1018.
   PubMed Web of Science ®Google Scholar
• Dineen J, Freeman R. Autonomic neuropathy. Semin Neurol. 2015;35(4):458–468.
   PubMed Web of Science ®Google Scholar
• Vernino S. Antibody testing as a diagnostic tool in autonomic disorders. Clin Auton Res. 2009;19(1):13–19.
   PubMed Web of Science ®Google Scholar
• Honnorat J, Antoine JC. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007;2:22.
   PubMed Web of Science ®Google Scholar
• Bischof A, Jaeger VK, Hadden RDM, et al. Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: insights from the DCVAS study. Neurol Neuroimmunol Neuroinflamm. 2019;6(6):e615.
   PubMed Web of Science ®Google Scholar
• Kovács L, Papós M, Takács R, et al. Autonomic nervous system dysfunction involving the gastrointestinal and the urinary tracts in primary Sjögren's syndrome. Clin Exp Rheumatol. 2003;21:697–703.
   PubMed Web of Science ®Google Scholar
• Cerinic MM, Generini S, Pignone A, et al. The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms. Rheum Dis Clin North Am. 1996;22(4):879–892.
   PubMed Web of Science ®Google Scholar
• Lorusso L, Hart IK, Ferrari D, et al. Autonomic paraneoplastic neurological syndromes. Autoimmun Rev. 2007;6(3):162–168.
   PubMed Web of Science ®Google Scholar
• Koike H, Tanaka F, Sobue G. Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. Curr Opin Neurol. 2011;24(5):504–510.
   PubMed Web of Science ®Google Scholar
• Kennedy PGE, Gershon AA. Clinical features of varicella-zoster virus infection. Viruses. 2018;10:609.
   PubMed Web of Science ®Google Scholar
• Fernandez A, Hontebeyrie M, Said G. Autonomic neuropathy and immunological abnormalities in Chagas' disease. Clin Auton Res. 1992;2(6):409–412.
   PubMedGoogle Scholar
• Mehta M, Rath GP, Padhy UP, et al. Intensive care management of patients with acute intermittent porphyria: clinical report of four cases and review of literature. Indian J Crit Care Med. 2010;14(2):88–91.
   PubMedGoogle Scholar
• Mitchell G, Larochelle J, Lambert M, et al. Neurologic crises in hereditary tyrosinemia. N Engl J Med. 1990;322(7):432–437.
   PubMed Web of Science ®Google Scholar
• El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics. 2013;10(2):186–198.
   PubMed Web of Science ®Google Scholar
• Eng CM, Germain DP, Banikazemi M, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006;8(9):539–548.
   PubMed Web of Science ®Google Scholar
• Sumida T, Tsuboi H, Iizuka M, et al. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome. Mod Rheumatol. 2013;23(5):841–845.
   PubMed Web of Science ®Google Scholar
• Mauduit P, Jammes H, Rossignol B. M3 muscarinic acetylcholine receptor coupling to PLC in rat exorbital lacrimal acinar cells. Am J Physiol. 1993;264(6 Pt 1):C1550–C1560.
   PubMedGoogle Scholar
• Proctor GB, Carpenter GH. Regulation of salivary gland function by autonomic nerves. Auton Neurosci. 2007;133:3–18.
   PubMed Web of Science ®Google Scholar
• Stengel PW, Yamada M, Wess J, et al. M(3)-receptor knockout mice: muscarinic receptor function in atria, stomach fundus, urinary bladder, and trachea. Am J Physiol Regul Integr Comp Physiol. 2002;282(5):R1443–R1449.
   PubMed Web of Science ®Google Scholar
• Robinson CP, Brayer J, Yamachika S, et al. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci U S A. 1998;95(13):7538–7543.
   PubMed Web of Science ®Google Scholar
• Kovács L, Török T, Bari F, et al. Impaired microvascular response to cholinergic stimuli in primary Sjögren's syndrome. Ann Rheum Dis. 2000;59:48–53.
   PubMed Web of Science ®Google Scholar
• Duray PH. Histopathology of clinical phases of human Lyme disease. Rheum Dis Clin N Am. 1989;15:691–710.
   PubMed Web of Science ®Google Scholar
• Månsson S, Ekberg O, Ohlsson B. Motility index measured by magnetic resonance enterography is associated with sex and mural thickness. World J Gastroenterol. 2020;26(36):5484–5497.
   PubMed Web of Science ®Google Scholar
• Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J Intern Med. 2019;285(4):352–366.
   PubMed Web of Science ®Google Scholar
• Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393–1407.
   Web of Science ®Google Scholar
• Andréasson K, Ohlsson B, Mandl T. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease. Arthritis Res Ther. 2016;18:9.
   PubMed Web of Science ®Google Scholar